Adaptimmune Therapeutics PLC Development Agreements
3 Contracts & Agreements
- Amendment Agreement No. 8 made and effective as of December 19, 2022 by and between Adaptimmune Limited and GlaxoSmithKline Intellectual Property Development Ltd (Filed With SEC on December 20, 2022)
- Amendment Agreement No. 6, dated July 20, 2018 between Adaptimmune Limited and GlaxoSmithKline Intellectual Property Development Ltd (Filed With SEC on August 2, 2018)
- Amendment Agreement No. 5, dated September 7, 2017 between Adaptimmune Limited and GlaxoSmithKline Intellectual Property Development Ltd (Filed With SEC on November 2, 2017)